‘Additionally, with these data, we continue being on monitor to begin major regulatory submissions in the second quarter of 2014. AbbVie will continue steadily to disclose additional detailed phase III study results at upcoming scientific congresses and in publications.’.. AbbVie’s PEARL-III study meets principal, secondary endpoints in sufferers with chronic GT1b HCV infection The first detailed results from AbbVie's pivotal stage III research, PEARL-III, were presented today within the 21st Meeting on Retroviruses and Opportunistic Infections press conference and can also be presented while a late-breaker in the conference on March 4.The outbreak is linked with methylprednisolone acetate steroid shots created by specialty pharmacy New England Compounding Middle. After contaminants were discovered within an unopened vial during an inspection at the Framingham, Mass., facility, three plenty of single-dosage vials of the steroid that were sent to 76 services in 23 U.S. States – – altogether 17,676 vials – – were recalled. States that received injections include: California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, NEW YORK, New Hampshire, NJ, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas and West Virginia.